herenciageneticayenfermedad: 150+ NEW key speakers announced

martes, 26 de junio de 2018

150+ NEW key speakers announced – 9th World Orphan Drug Congress

Dear Victor Norberto,

With our strongest ever agenda for the 9^th World Orphan Drug Congress, taking place 6^th- 8^th November, Barcelona, I’m sure these dates are already penciled into your diary. But have you downloaded the brand new brochure which provides exclusive information on all of our latest speakers and agenda improvements? If not, be sure to stay at the forefront of the Orphan Drug sector by downloading the brochure.

VIEW THE 2018 AGENDA

How does the World Orphan Drug Congress differ to other Orphan events?

REPUTATION – Now in its 9^th year the World Orphan Drug Congress is well established and is the biggest multi-stakeholder rare disease event in Europe. With the help from ourAdvisory Board and a unique combination of engaging plenary sessions led by key speakers, industry relevant case studies, interactive roundtable sessions and superb networking activities, this event offers delegates an exclusive networking platform and learning experience.

CONTENT – As the Orphan space grows as has the congress! We have continued to grow the congress with even more scope, breadth and relevant content in Patient Access, HTA Alignment, Pricing and Reimbursement, Patient Advocacy, Clinical & Product Development, Partnering, Cell & Gene Therapy and Science & Strategy.

SPEAKERS - Hear from 150+ high-level big pharma, biotech, government, payers, regulator and PAG speakers including: EURORDIS, NORD, European Commission, EFPIA, EUCOPE, - G-BA, H-AS, NHS, NICE, AIFA, ZIN and many more.

As a professional in the Orphan Diseases Sector we understand how hard it is to keep up with the latest developments globally, which is why we bring you this concise 3 day event: 9^th year the World Orphan Drug Congress to bring you up to speed with everything in areas from clinical development, regulation, pricing and reimbursement, patient access to advocacy.